BeOne Medicines (ONC) Exchange Rate Effect (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Exchange Rate Effect of $19.3 million for Q1 2026, up 455.17% year-over-year from $3.5 million in Q1 2025, and down 16.59% quarter-over-quarter from $23.2 million in Q4 2025.
BeOne Medicines (ONC) Exchange Rate Effect (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Exchange Rate Effect for 12 consecutive years, with $19.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 455.17% year-over-year to $19.3 million; the TTM figure through Mar 2026 stood at $75.9 million (up 394.19% YoY), while the FY2025 annual figure was $60.0 million, up 216.09% from the prior year.
- Exchange Rate Effect slipped to $19.3 million in Q1 2026 per ONC's latest filing, from $23.2 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $64.5 million in Q4 2022 and bottomed at -$80.2 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$2.9 million across 5 years, with a median of $9.0 million in 2022.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 4247.95% — and 2024, when it jumped 5299.62%.
- BeOne Medicines' Exchange Rate Effect stood at $64.5 million in 2022, then slumped by 34.52% to $42.3 million in 2023, then plunged by 222.35% to -$51.7 million in 2024, then soared by 144.79% to $23.2 million in 2025, then declined by 16.59% to $19.3 million in 2026.
- Business Quant data shows ONC's Exchange Rate Effect at $19.3 million in Q1 2026, $23.2 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 315,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.84 Mn |
| Jun 30, 2026 | 19.84 Mn |
| Mar 31, 2026 | 19.32 Mn |
| Mar 31, 2026 | 19.32 Mn |
| Dec 31, 2025 | 23.16 Mn |
| Dec 31, 2025 | 23.16 Mn |
| Sep 30, 2025 | 9.91 Mn |
| Sep 30, 2025 | 9.91 Mn |
| Jun 30, 2025 | 23.48 Mn |
| Jun 30, 2025 | 23.48 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | -51.71 Mn |
| Dec 31, 2024 | -51.71 Mn |
| Sep 30, 2024 | 28.35 Mn |
| Sep 30, 2024 | 28.35 Mn |
| Jun 30, 2024 | -5.90 Mn |
| Jun 30, 2024 | -5.90 Mn |
| Mar 31, 2024 | -22.44 Mn |
| Mar 31, 2024 | -22.44 Mn |